Seres Therapeutics (MCRB) Stock: Why The Price Increased Today

By Amit Chowdhry ● Nov 24, 2021
  • The stock price of Seres Therapeutics Inc (NASDAQ: MCRB) slightly increased pre-market today. This is why it happened.

The stock price of Seres Therapeutics Inc (NASDAQ: MCRB) – a leading microbiome therapeutics company – slightly increased pre-market today. Investors are responding positively to Seres Therapeutics announcing that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, participated in a pre-recorded fireside chat as part of the Piper Sandler 33rd Annual Virtual Healthcare Conference – which will take place November 29 – December 2, 2021. The fireside chat is going to be available for on-demand viewing on the Seres website.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.